Preclinical DiCE Molecules will roll its dice to Wall Street amid biotech IPO frenzy
DiCE Molecules wants to join the party, albeit not in Las Vegas but on Wall Street, with another preclinical biotech IPO as it goes up against psoriasis giants from Novartis, Eli Lilly and Amgen.